ConductScience.org, home

Paper3694494

Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles.

Shaw PN and 1 other. J Pharmacokinet Biopharm, 1987. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles. Papers, record 3694494. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3694494

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2019-10-22
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shaw PNP N
2Houston JBJ B

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug InteractionsMajor topic
Pharmaceutical PreparationsMajor topic
Half-Life
Kinetics
Metabolic Clearance Rate
Models, Biological

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12870906Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.Drug Metab Dispos1986https://conductscience.org/library/papers/2870906PubMed
27028434Inhibitors of Cytochrome P-450s and their mechanism of action.Drug Metab Rev1981https://conductscience.org/library/papers/7028434PubMed
32864708Drug interactions with cimetidine: an update.Pharmacol Ther1985https://conductscience.org/library/papers/2864708PubMed
43718541New heterocyclic modifiers of oxidative drug metabolism--I. 6-Substituted-2-aminobenzothiazoles.Biochem Pharmacol1986https://conductscience.org/library/papers/3718541PubMed
53924056Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.Biochem Pharmacol1985https://conductscience.org/library/papers/3924056PubMed
67034002Kinetics of drug--drug interactions.Pharmacol Ther1981https://conductscience.org/library/papers/7034002PubMed
76130930Review of cimetidine drug interactions.Drug Intell Clin Pharm1983https://conductscience.org/library/papers/6130930PubMed
87048351Drug metabolite kinetics.Pharmacol Ther1981https://conductscience.org/library/papers/7048351PubMed
93729972The nature of microsomal monooxygenase inhibition by cimetidine.Biochem Pharmacol1986https://conductscience.org/library/papers/3729972PubMed
106516440Inhibition of antipyrine metabolite formation in rats in vivo.Xenobiotica1984https://conductscience.org/library/papers/6516440PubMed
116487376In vitro effects of quinoline derivatives on cytochrome P-450 and aminopyrine N-demethylase activity in rat hepatic microsomes.Biochem Pharmacol1984https://conductscience.org/library/papers/6487376PubMed
122881749Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.Drug Metab Dispos1987https://conductscience.org/library/papers/2881749PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
14651727Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.Br J Clin Pharmacol2003https://conductscience.org/library/papers/14651727PubMed
12908853Factors affecting the clinical development of cytochrome p450 3A substrates.Clin Pharmacokinet2003https://conductscience.org/library/papers/12908853PubMed
2266497Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.J Pharmacokinet Biopharm1990https://conductscience.org/library/papers/2266497PubMed
2177401Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2177401PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3694494

GET https://conductscience.org/api/papers/v1/3694494/authors